Marcia Cruz-Correa to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Marcia Cruz-Correa has written about Randomized Controlled Trials as Topic.
Connection Strength
0.111
-
Moehler M, Oh DY, Kato K, Arkenau T, Tabernero J, Lee KW, Rha SY, Hirano H, Spigel D, Yamaguchi K, Wyrwicz L, Disel U, Pazo-Cid RA, Fornaro L, Xu Y, Sheng T, Yang S, Kadva A, Cruz-Correa M, Xu RH. First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression?=?1%: A Retrospective Analysis of RATIONALE-305. Adv Ther. 2025 May; 42(5):2248-2268.
Score: 0.051
-
Anderson JC, Morris CB, Robertson DJ, Barry ELR, Figueiredo JC, Cruz-Correa M, Bostick RM, Ahnen DJ, Baron JA. Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia? J Clin Gastroenterol. 2018 08; 52(7):628-634.
Score: 0.032
-
Lieberman D, Ladabaum U, Cruz-Correa M, Ginsburg C, Inadomi JM, Kim LS, Giardiello FM, Wender RC. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review. JAMA. 2016 Nov 22; 316(20):2135-2145.
Score: 0.029